Skip to the content
Transaction register
Lawton Level One Intelligence BriefIndustrial policyDeployed

TSMC in Arizona: a first plant that produced, and four announcements that have not yet

A United States manufacturing programme committed in May 2020 at $12 billion for one fabrication plant and restated through successive expansions to $165 billion in March 2025. The first plant entered high-volume production of 4-nanometre chips in the fourth quarter of 2024.

Headline figure
$165.00bn
What that figure measures
Total planned United States investment as restated on 3 March 2025, aggregating four successive commitments. Not an amount spent, and not the value of any single facility.
Announced
May 15, 2020
Confidence
High

Where it sits

The central judgment

Arizona is the case that contradicts the assumption that these plants are announced and never built: the first facility is producing, on the promised process, within roughly four years of the announcement. It does not contradict the second assumption, that the announced figures run far ahead of the money. The headline has risen from $12 billion to $165 billion across four commitments, and only one of them has a working plant behind it.

High for the first facility's production and for the sequence of announced figures. Low for the economics of any phase.

StateDeployed
  1. 01AnnouncedStated publicly. No decision has been taken that binds anyone.
  2. 02AuthorizedA body with the standing to do so has approved it. Approval is not payment.
  3. 03ContractedDefinitive documents bind the parties. A signed agreement is not yet a funded one.
  4. 04FundedThe money has been committed to the recipient. Committed is not spent.
  5. 05DeployedThe money has been spent on the thing it was for.
  6. 06RealizedThe outcome the money was for has actually occurred and been measured.
00

How it formed

What commercial need, strategic objective or market condition made the arrangement mutually worth doing before anyone announced it.

The company's stated objective was geographic diversification of leading-edge capacity and proximity to United States customers. The federal objective was advanced manufacturing on American soil; the state's was a semiconductor cluster around Phoenix.

Earliest verified evidence
The company's announcement of intent in May 2020, following site discussions in 2019 and 2020 that this record does not reconstruct.
Parties documented at formation
Taiwan Semiconductor Manufacturing Company, TSMC Arizona Corporation, United States Department of Commerce, State of Arizona

What was changing

  • Federal semiconductor incentives enacted in August 2022
  • Customer pressure for a United States leading-edge source, and the concentration of leading-edge capacity in Taiwan

What else was on the table

  • Other United States sites were reported to have been considered before Phoenix was selected. The shortlist is not established here.

What the formation record does not establish

  • The cost of building in Arizona relative to Taiwan is not established in this record.
  • The share of output committed to particular customers is not established here.
01

The development

What happened, what is new, and what is actually established.

Committed in May 2020 at $12 billion for one plant; restated at $40 billion in December 2022, $65 billion in April 2024 and $165 billion in March 2025. The first plant entered high-volume production of 4-nanometre chips in the fourth quarter of 2024. What is established is that one facility was built and is producing, and that the headline figure is an accumulation of announcements rather than a budget.

Record
Announced May 15, 2020
Record
Stated for Phoenix, Maricopa County, Arizona
Record
Headline figure $165.00bn — Total planned United States investment as restated on 3 March 2025, aggregating four successive commitments. Not an amount spent, and not the value of any single facility.
02

The underlying structure

How the transaction, policy, market or system actually works.

Each expansion is a separate commitment layered on the last, so the headline records intent across a decade while a single facility carries the demonstrated capability. Federal support arrives against milestones, which places the public claim on output rather than on the announced total. The company retains the option not to build later phases.

03

The parties and incentives

Who participates, what each party seeks, and what leverage each holds.

4 parties established by evidence. TSMC Arizona Corporation, Taiwan Semiconductor Manufacturing Company, State of Arizona, United States Department of Commerce.

TSMC Arizona Corporation

Project vehicleArizona, United States

The United States vehicle that holds and operates the Arizona facilities.

Contributes
Operations
Pursues
Execution of the announced phases
Leverage
Not established
Exposure
Not established

Inferred from the vehicle's role, recorded as a reading.

Taiwan Semiconductor Manufacturing Company

CorporationTaiwan

Parent and technology provider. Supplies the process technology and the capital behind each announced phase.

Contributes
Capital · Process technology · Customer relationships
Pursues
Geographic diversification of leading-edge capacity · Proximity to United States customers
Leverage
Control over whether later phases are built, which no agreement compels.
Exposure
Not established

Stated by the company at announcement.

State of Arizona

GovernmentArizona, United States

Host state, supplying site support and state incentives around a Phoenix cluster.

Contributes
Site support · State incentives
Pursues
A semiconductor cluster within the state
Leverage
Not established
Exposure
Not established

Inferred from the state's role in the siting, recorded as a reading.

United States Department of Commerce

Government agencyUnited States

Provider of federal semiconductor awards against construction and production milestones.

Contributes
Grants
Pursues
Advanced manufacturing capacity on United States soil
Leverage
Not established
Exposure
Awards conditioned on milestones the recipient reports against.

Stated in the federal award programme.

04

The money, assets, rights and obligations

Who supplies capital, who owns what, who controls decisions, who bears risk, and who captures returns.

2 flows of capital and 0 ownership interests recorded.

  • United States Department of Commerce → TSMC Arizona CorporationGrantAuthorized

    $6.60bn

    Stated gross

    Period
    Not established
    Announced
    Not established
    Repayment
    Not established
    Return to provider
    Not established

    Conditions

    • Construction and production milestones

    Uncertain

    • Confirmed in November 2024. The disbursement schedule, and the conditions attaching to later phases, are not established here.
  • Taiwan Semiconductor Manufacturing Company → Not establishedPrivate capitalAnnounced

    $165.00bn

    Stated gross

    Period
    Aggregate of four commitments, 2020 to 2025
    Announced
    Not established
    Repayment
    Not established
    Return to provider
    Not established

    Uncertain

    • An aggregate of four separate announcements across a decade, not a budget for any one facility. Only the first plant is built.

What each instrument means for the public exposure

  • Grant. Public money given without repayment. The public exposure is the full amount.
  • Private capital. Capital from outside the public sector. It is not public expenditure.

The valuation benchmark

M&A Multiples Index · ExitValue.ai

The register does not classify this arrangement to a sub-vertical, so no benchmark is applied. No multiple is inferred from the figure it states, because a price without a comparable set establishes nothing about whether that price was ordinary.

No ownership interest or project asset has been established by the evidence held.

No commitment, risk allocation or return mechanism has been established by the evidence held.

05

The causal intelligence

Why the development is occurring, and which alternative explanations remain plausible.

Not established from the evidence held.

No causal mechanism has been established by the evidence held.

06

The strategic implication

What changes for the customer, the counterparties, or the relevant institutions.

For a customer, the relevant question is capability rather than headline: one Arizona plant on 4-nanometre is a real second source, while the packaging and leading-edge capacity that would matter most remain unbuilt. For a competitor or a government, the comparison to hold is cost per wafer against Taiwan, which no announcement discloses.

07

The comparative intelligence

Precedents, alternative structures, and what transfers to another context.

Not established from the evidence held.

A comparable is a precedent, not a forecast. The cases above share purpose, state, market or stated geography with this arrangement; none of that establishes how this one will end.

08

The forward view

Scenarios, triggers, leading indicators, deadlines and conditional consequences.

Not established from the evidence held.

No leading indicator has been established for this assessment.

09

The decision

Concrete priorities, options, negotiation points, and what would change the recommendation.

Not established from the evidence held.

No decision implication has been established for this transaction.

10

The evidence position

Traceable sources, material limitations, unresolved facts, and calibrated confidence.

Production start and process node are documented by the company and confirmed by the federal government. The expanded commitments are announcements. Cost per wafer, yield economics and the return on each phase are not established.

Unresolved questions

Each is the specific agreement, disclosure, valuation or term that would materially change the reading. They are stated rather than filled with estimated provisions.

  • What does a wafer cost to make in Arizona relative to Taiwan?

    Whether the plant is a durable source or a subsidised hedge.

  • Which later phases have committed customer volume behind them?

    Whether the $165 billion is a plan or a sequence of options.

Uncertainty in the record

  • Confirmed in November 2024. The disbursement schedule, and the conditions attaching to later phases, are not established here.
  • An aggregate of four separate announcements across a decade, not a budget for any one facility. Only the first plant is built.

Limitations

  • This record holds the first facility's production and the sequence of announced commitments. It does not establish capital deployed per phase, cost per wafer, or which later phases will be built.
  • An expansion reported after the date of this record is not included here.
11

What it produced

How the arrangement ended, what has been measured against its stated objective, and what the evidence still cannot establish.

In progress

Still moving through its stages. No final result has occurred, so nothing recorded against it is a realized outcome.

Completed
Not established
Announcement to completion
4.8 years
Outcome confidence
High

Financial result

No financial result is recorded. The first facility is in production; no revenue or return is established by this record.

Progress against the stated objective

The first plant entered high-volume production of 4-nanometre chips in the fourth quarter of 2024, reported at roughly 10,000 wafers per month against a stated target of 30,000. Five further plants, two advanced packaging facilities and a research centre are planned. The 6,000 direct jobs stated for the first three plants have not been established as achieved.

Integration and delivery

The first plant is operational and reported to be producing for United States customers. Later phases are at construction and announcement stage.

Milestones, and the time between them

  1. May 15, 2020 · the same day after the previous milestone

    Announced: $12 billion, one plant

  2. Dec 6, 2022 · 2.6 years after the previous milestone

    Expanded to $40 billion, two plants

  3. Apr 8, 2024 · 16 months after the previous milestone

    Expanded to $65 billion, three plants

  4. Dec 1, 2024 · 8 months after the previous milestone

    First plant enters high-volume 4-nanometre production

  5. Mar 3, 2025 · 3 months after the previous milestone

    Expanded to $165 billion: six plants, two packaging facilities and a research centre

What the outcome record does not establish

  • Capital deployed per phase is not established here.
  • The economics of the first plant are not established: cost per wafer, yield and utilisation are undisclosed.

Methods applied

What this reading was built with.

8 methods are supported by the evidence held, and 2 are withheld for want of it. A method runs where its required evidence exists and its deal type applies; one that does not run is stated with the evidence it is missing, so the reading says what it is not based on.

  1. Transaction structure and milestone analysis

    Reconstruct the movement of the arrangement from the record: what was announced, what was authorized, what was contracted, and how long each step actually took.

    5 dated milestones are held against the arrangement.

    Assumptions
    The state recorded for the arrangement is the furthest state the evidence establishes, not the furthest one described.
    Does not establish
    A milestone the source did not date is not given an inferred one, so elapsed time is computed only between dated events. Silence between two milestones is not evidence that nothing happened.
  2. Strategic rationale and synergy assessment

    Establish, from the parties' own statements where they exist, what the arrangement was for and whether the stated objective is one the structure can deliver.

    A documented rationale is recorded against the arrangement.

    Assumptions
    A stated rationale is a claim by the party making it, and is reported as theirs rather than adopted as the reading.
    Does not establish
    Private strategic motives are not recorded anywhere public and are not inferred from the deal's shape. An announced synergy is a projection until an outcome is measured against it.
  3. Valuation and financial analysis

    Read the disclosed figure for what it actually measures, and state what can and cannot be concluded from it.

    A headline figure is held with its basis: Total planned United States investment as restated on 3 March 2025, aggregating four successive commitments. Not an amount spent, and not the value of any single facility..

    Assumptions
    The figure is taken exactly as disclosed, and is not recomputed from other figures.
    Does not establish
    A programme total, a committed public contribution and a private investment are different bases and are never summed into one value. An undisclosed consideration is not estimated from the market price of comparable assets.
  4. Capital structure and financing analysis

    Separate what was given, lent, guaranteed, granted or foregone, and show which party carries each form of exposure.

    2 capital flows and 0 ownership interests are recorded.

    Assumptions
    The instrument recorded is the instrument the source states, and a reallocation inside an existing award is not new money.
    Does not establish
    Undisclosed financing terms remain unknown; a plausible structure is not substituted for the missing one. Deferred, contingent and conditioned tranches are marked as such and are not counted as money in motion.
  5. Counterparty, competitive and industry analysis

    Establish who is actually at the table and what each side can withhold or supply, without reading a competitive position from an industry list.

    4 parties are established by evidence.

    Assumptions
    A party's role in this arrangement is the role the source states, not the one its sector implies.
    Does not establish
    Absence from the record is not absence from the deal; undisclosed participants are unknown, not excluded. Competitive consequence is a reading and is labelled as one.
  6. Negotiation and decision-point analysis

    Identify the decisions the arrangement turns on, who faces them, and what would change each one — the layer where intelligence becomes actionable.

    The decisions the arrangement turns on, or the alternatives its parties weighed, are recorded.

    Assumptions
    A decision recorded against an audience is one the evidence makes available to them; whether they pursue it is not held anywhere.
    Does not establish
    Private negotiation history is not reconstructed. Where no record exists, the negotiation is reported as not established. A stated position is not a bargaining position.
  7. Post-transaction integration and outcome analysis

    Establish whether the arrangement delivered the objective it was made for, measured against what was stated beforehand.

    An outcome status is recorded, so what the arrangement produced can be measured.

    Assumptions
    Only outcomes the record states are measured; where none exists, the assessment says so rather than grading progress.
    Does not establish
    A completed transaction is not a delivered objective, and a delivered objective is not a financial return. Where the arrangement is still in progress, projected figures are labelled as projections and are never reported as results.
  8. Comparative case analysis

    Place the arrangement against recorded cases that share enough of its structure to be informative, and say what transfers.

    1 recorded case matches this arrangement on two or more dimensions.

    Assumptions
    Shared purpose, state, market or geography make a case readable as precedent, not predictive of this outcome.
    Does not establish
    This is association, not causation. A precedent that went one way does not establish that this arrangement will. Sample size, period and selection bias are stated wherever a pattern across cases is claimed.

Methods withheld, and why

  • Relationship and supply-chain analysis

    Nothing is recorded that would connect the arrangement to an asset, an obligation or a position.

  • Deal failure and risk analysis

    No risk is allocated in the record and the arrangement is not recorded as terminated.